Gilead asks FDA again to approve twice-a-year HIV-fighting drug
June 27, 2022 at 19:37 PM EDT
The drug, called lenacapavir, was rejected by the FDA in February because of issues with the vials holding the injectable drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|